TY  - GEN
AU  - Robinson,Giles W
AU  - Rudneva,Vasilisa A
AU  - Buchhalter,Ivo
AU  - Billups,Catherine A
AU  - Waszak,Sebastian M
AU  - Smith,Kyle S
AU  - Bowers,Daniel C
AU  - Bendel,Anne
AU  - Fisher,Paul G
AU  - Partap,Sonia
AU  - Crawford,John R
AU  - Hassall,Tim
AU  - Indelicato,Daniel J
AU  - Boop,Frederick
AU  - Klimo,Paul
AU  - Sabin,Noah D
AU  - Patay,Zoltan
AU  - Merchant,Thomas E
AU  - Stewart,Clinton F
AU  - Orr,Brent A
AU  - Korbel,Jan O
AU  - Jones,David T W
AU  - Sharma,Tanvi
AU  - Lichter,Peter
AU  - Kool,Marcel
AU  - Korshunov,Andrey
AU  - Pfister,Stefan M
AU  - Gilbertson,Richard J
AU  - Sanders,Robert P
AU  - Onar-Thomas,Arzu
AU  - Ellison,David W
AU  - Gajjar,Amar
AU  - Northcott,Paul A
TI  - Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
SN  - 1474-5488
PY  - 2019///0409
KW  - Age Factors
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Australia
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Cerebellar Neoplasms
KW  - Chemotherapy, Adjuvant
KW  - Child, Preschool
KW  - Clinical Decision-Making
KW  - Cranial Irradiation
KW  - DNA Methylation
KW  - Gene Expression Profiling
KW  - Humans
KW  - Infant
KW  - Medulloblastoma
KW  - Neoadjuvant Therapy
KW  - Patient Selection
KW  - Predictive Value of Tests
KW  - Progression-Free Survival
KW  - Radiation Dosage
KW  - Radiotherapy, Adjuvant
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - United States
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(18)30204-3
ER  -